Analysis reveals that DNA methylation levels can better identify cancer mortality risk in individuals, suggesting improved methods for risk assessment.
Supplementary Figure S5 shows HRs for each cause of mortality stratified by YSQ and AHRR DNAm after adjusting for passive smoking.
No takes yet. Share an insight, caveat, or question.
Tsuboi et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: